• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体一碳代谢与阿尔茨海默病。

Mitochondrial One-Carbon Metabolism and Alzheimer's Disease.

机构信息

MRC Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK.

出版信息

Int J Mol Sci. 2024 Jun 7;25(12):6302. doi: 10.3390/ijms25126302.

DOI:10.3390/ijms25126302
PMID:38928008
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11203557/
Abstract

Mitochondrial one-carbon metabolism provides carbon units to several pathways, including nucleic acid synthesis, mitochondrial metabolism, amino acid metabolism, and methylation reactions. Late-onset Alzheimer's disease is the most common age-related neurodegenerative disease, characterised by impaired energy metabolism, and is potentially linked to mitochondrial bioenergetics. Here, we discuss the intersection between the molecular pathways linked to both mitochondrial one-carbon metabolism and Alzheimer's disease. We propose that enhancing one-carbon metabolism could promote the metabolic processes that help brain cells cope with Alzheimer's disease-related injuries. We also highlight potential therapeutic avenues to leverage one-carbon metabolism to delay Alzheimer's disease pathology.

摘要

线粒体一碳代谢为包括核酸合成、线粒体代谢、氨基酸代谢和甲基化反应在内的多个途径提供碳单位。迟发性阿尔茨海默病是最常见的与年龄相关的神经退行性疾病,其特征是能量代谢受损,并且可能与线粒体生物能学有关。在这里,我们讨论了与线粒体一碳代谢和阿尔茨海默病相关的分子途径之间的交叉点。我们提出,增强一碳代谢可以促进帮助脑细胞应对与阿尔茨海默病相关损伤的代谢过程。我们还强调了利用一碳代谢来延缓阿尔茨海默病病理的潜在治疗途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7828/11203557/ed30f42bf530/ijms-25-06302-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7828/11203557/2ce102594be1/ijms-25-06302-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7828/11203557/4bf4371e6c5e/ijms-25-06302-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7828/11203557/b6dc03167d01/ijms-25-06302-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7828/11203557/ed30f42bf530/ijms-25-06302-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7828/11203557/2ce102594be1/ijms-25-06302-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7828/11203557/4bf4371e6c5e/ijms-25-06302-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7828/11203557/b6dc03167d01/ijms-25-06302-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7828/11203557/ed30f42bf530/ijms-25-06302-g004.jpg

相似文献

1
Mitochondrial One-Carbon Metabolism and Alzheimer's Disease.线粒体一碳代谢与阿尔茨海默病。
Int J Mol Sci. 2024 Jun 7;25(12):6302. doi: 10.3390/ijms25126302.
2
Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions.晚期阿尔茨海默病患者大脑代谢的转变:对生物标志物和治疗干预的影响。
Mol Aspects Med. 2011 Aug;32(4-6):247-57. doi: 10.1016/j.mam.2011.10.005. Epub 2011 Oct 21.
3
White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.脑老化女性白质脂质作为生酮供能物质:对阿尔茨海默病的影响。
EBioMedicine. 2015 Nov 3;2(12):1888-904. doi: 10.1016/j.ebiom.2015.11.002. eCollection 2015 Dec.
4
A mitochondrial bottleneck hypothesis of Alzheimer's disease.阿尔茨海默病的线粒体瓶颈假说。
Mol Med Today. 1995 Aug;1(5):240-7. doi: 10.1016/s1357-4310(95)91532-x.
5
Mitochondrial alterations in Alzheimer's disease.阿尔茨海默病中的线粒体改变
J Alzheimers Dis. 2006 Jul;9(2):119-26. doi: 10.3233/jad-2006-9204.
6
Maintenance of mitochondrial homeostasis for Alzheimer's disease: Strategies and challenges.维持线粒体动态平衡治疗阿尔茨海默病:策略与挑战。
Redox Biol. 2023 Jul;63:102734. doi: 10.1016/j.redox.2023.102734. Epub 2023 May 6.
7
Defective Mitochondrial Pyruvate Flux Affects Cell Bioenergetics in Alzheimer's Disease-Related Models.线粒体丙酮酸通量缺陷影响阿尔茨海默病相关模型中的细胞生物能量学。
Cell Rep. 2020 Feb 18;30(7):2332-2348.e10. doi: 10.1016/j.celrep.2020.01.060.
8
Modulation of Mitochondrial Function as a Therapeutic Strategy for Neurodegenerative Diseases.作为神经退行性疾病治疗策略的线粒体功能调节。
J Prev Alzheimers Dis. 2023;10(4):675-685. doi: 10.14283/jpad.2023.108.
9
Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.脑线粒体功能障碍作为阿尔茨海默病与糖尿病之间的联系。
J Neurol Sci. 2007 Jun 15;257(1-2):206-14. doi: 10.1016/j.jns.2007.01.017. Epub 2007 Feb 20.
10
The Role of Bioenergetics in Neurodegeneration.生物能量学在神经退行性变中的作用。
Int J Mol Sci. 2022 Aug 16;23(16):9212. doi: 10.3390/ijms23169212.

引用本文的文献

1
Signs of Alzheimer's Disease: Tied to Aging.阿尔茨海默病的迹象:与衰老相关。
Int J Mol Sci. 2025 May 22;26(11):4974. doi: 10.3390/ijms26114974.
2
Acetylcholinesterase inhibitors considerably affect the salivary microbiome in patients with Alzheimer's disease.乙酰胆碱酯酶抑制剂对阿尔茨海默病患者的唾液微生物群有显著影响。
iScience. 2025 May 6;28(6):112593. doi: 10.1016/j.isci.2025.112593. eCollection 2025 Jun 20.
3
Special Issue "Mitochondrial Metabolism Alterations in Health and Disease".特刊“健康与疾病中的线粒体代谢改变”。

本文引用的文献

1
Intervention with metabolites emulating endogenous cell transitions accelerates muscle regeneration in young and aged mice.模拟内源性细胞转变的代谢物干预可加速年轻和老年小鼠的肌肉再生。
Cell Rep Med. 2024 Mar 19;5(3):101449. doi: 10.1016/j.xcrm.2024.101449.
2
N1-methylation of adenosine (mA) in ND5 mRNA leads to complex I dysfunction in Alzheimer's disease.N1-甲基腺苷(mA)在 ND5 mRNA 中的甲基化导致阿尔茨海默病中复合物 I 功能障碍。
Mol Psychiatry. 2024 May;29(5):1427-1439. doi: 10.1038/s41380-024-02421-y. Epub 2024 Jan 29.
3
Vitamin B is a limiting factor for induced cellular plasticity and tissue repair.
Int J Mol Sci. 2025 May 18;26(10):4826. doi: 10.3390/ijms26104826.
4
Enhancing mitochondrial one-carbon metabolism is neuroprotective in Alzheimer's disease models.增强线粒体一碳代谢对阿尔茨海默病模型具有神经保护作用。
Cell Death Dis. 2024 Nov 24;15(11):856. doi: 10.1038/s41419-024-07179-3.
5
Associations between Circulating Biomarkers of One-Carbon Metabolism and Mitochondrial D-Loop Region Methylation Levels.一碳代谢循环生物标志物与线粒体D-环区域甲基化水平之间的关联。
Epigenomes. 2024 Oct 9;8(4):38. doi: 10.3390/epigenomes8040038.
维生素 B 是诱导细胞可塑性和组织修复的限制因素。
Nat Metab. 2023 Nov;5(11):1911-1930. doi: 10.1038/s42255-023-00916-6. Epub 2023 Nov 16.
4
Immunological characterization and diagnostic models of RNA N6-methyladenosine regulators in Alzheimer's disease.阿尔茨海默病中 RNA N6-甲基腺苷调节因子的免疫特征和诊断模型。
Sci Rep. 2023 Sep 4;13(1):14588. doi: 10.1038/s41598-023-41129-x.
5
Universal DNA methylation age across mammalian tissues.跨哺乳动物组织的通用 DNA 甲基化年龄。
Nat Aging. 2023 Sep;3(9):1144-1166. doi: 10.1038/s43587-023-00462-6. Epub 2023 Aug 10.
6
Investigation of hydrated channels and proton pathways in a high-resolution cryo-EM structure of mammalian complex I.哺乳动物复合体 I 高分辨率冷冻电镜结构中水通道和质子途径的研究。
Sci Adv. 2023 Aug 2;9(31):eadi1359. doi: 10.1126/sciadv.adi1359.
7
Characterization of Mitochondrial DNA Methylation of Alzheimer's Disease in Plasma Cell-Free DNA.血浆游离DNA中阿尔茨海默病线粒体DNA甲基化的特征分析
Diagnostics (Basel). 2023 Jul 12;13(14):2351. doi: 10.3390/diagnostics13142351.
8
Mitochondrial DNA methylation and mitochondria-related epigenetics in neurodegeneration.神经退行性变中的线粒体DNA甲基化与线粒体相关表观遗传学
Neural Regen Res. 2024 Feb;19(2):405-406. doi: 10.4103/1673-5374.379045.
9
ALDH1L2 regulation of formate, formyl-methionine, and ROS controls cancer cell migration and metastasis.醛脱氢酶1家族成员L2(ALDH1L2)对甲酸、甲酰甲硫氨酸和活性氧的调节控制着癌细胞的迁移和转移。
Cell Rep. 2023 Jun 27;42(6):112562. doi: 10.1016/j.celrep.2023.112562. Epub 2023 May 26.
10
Targeting the biology of aging with mTOR inhibitors.用 mTOR 抑制剂靶向衰老的生物学。
Nat Aging. 2023 Jun;3(6):642-660. doi: 10.1038/s43587-023-00416-y. Epub 2023 May 4.